Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  4,983 نتائج ل ""DOXORUBICIN""

فلترة النتائج

Subject : vincristine
إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Deranged cytokine levels are linked to cancer-related cognitive impairment in lymphoma patients receiving R-CHOP chemotherapy.

  • Authors : Mishra P; Department of Translational and Clinical Research, School of Chemical and Life Sciences, Jamia Hamdard, New Delhi, India.; Bhurani D

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/adverse effects

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2025 Mar; Vol. 66 (3), pp. 516-528. Date of Electronic Publication: 2024 Nov 15.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

FCRL1 and BAFF mRNA Expression as Novel Diagnostic and Prognostic Biomarkers in Diffuse Large B-Cell Lymphoma: Expression Signatures Predict R-CHOP Therapy Response and Survival.

  • Authors : Al-Amodi HS; Biochemistry Department, Faculty of Medicine, Umm Al-Qura University, Makkah 21955, Saudi Arabia.; Bedair HM

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/genetics ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/diagnosis

  • Source: International journal of molecular sciences [Int J Mol Sci] 2025 Jan 31; Vol. 26 (3). Date of Electronic Publication: 2025 Jan 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Baseline [ 18 F]FDG PET/CT radiomics for predicting interim efficacy in follicular lymphoma treated with first-line R-CHOP.

  • Authors : Wen Z; Department of Radiology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, China.; Gao X

Subjects: Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/diagnostic imaging ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/drug therapy ; Lymphoma, Follicular*/Lymphoma, Follicular*/Lymphoma, Follicular*/pathology

  • Source: BMC cancer [BMC Cancer] 2025 Jan 23; Vol. 25 (1), pp. 128. Date of Electronic Publication: 2025 Jan 23.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Successful Treatment of a Patient Presenting with Simultaneous Diffuse Large B-Cell Lymphoma and Hodgkin Lymphoma: A Case Report.

  • Authors : Lee J; Department of Hematology/Oncology, Kyungpook National University Chilgok Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.; Han MH

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/drug therapy ; Hodgkin Disease*/Hodgkin Disease*/Hodgkin Disease*/therapy

  • Source: The American journal of case reports [Am J Case Rep] 2025 Jan 03; Vol. 26, pp. e945435. Date of Electronic Publication: 2025 Jan 03.Publisher: International Scientific Information, Inc Country of Publication: United States NLM ID: 101489566 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The impact of initial tumor bulk in DLBCL treated with DA-EPOCH-R vs. R-CHOP: a secondary analysis of alliance/CALGB 50303.

  • Authors : Lanier CM; Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA.; Razavian NB

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/pathology EPOCH protocol

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (14), pp. 2199-2206. Date of Electronic Publication: 2024 Sep 05.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

The impact of trial inclusion criteria on outcomes in DLBCL patients treated with R-CHOP in the first line: a Danish nationwide study.

  • Authors : Simonsen MR; Department of Hematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.; Haunstrup LM

Subjects: Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/Antineoplastic Combined Chemotherapy Protocols*/adverse effects ; Vincristine*/Vincristine*/Vincristine*/therapeutic use

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Dec; Vol. 65 (14), pp. 2173-2181. Date of Electronic Publication: 2024 Sep 03.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Prediction model of male reproductive function damage caused by CHOP chemotherapy regimen for non-Hodgkin's lymphoma.

  • Authors : Zhang J; Key Laboratory of Biomedical Information Engineering of Ministry of Education, School of Life Science and Technology, Xi'an Jiaotong University, Xi'an City, Shanxi Province, 710049, China.; Department of Hematology, The First Affiliated Hospital of Xiamen University, Xiamen City, Fujian Province, 361000, China.

Subjects: Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/adverse effects ; Cyclophosphamide*/Cyclophosphamide*/Cyclophosphamide*/administration & dosage ; Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/Lymphoma, Non-Hodgkin*/drug therapy CHOP protocol

  • Source: BMC cancer [BMC Cancer] 2024 Nov 12; Vol. 24 (1), pp. 1391. Date of Electronic Publication: 2024 Nov 12.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A retrospective cohort study describing chemotherapy-induced peripheral neuropathy in Non-Hodgkin lymphoma patients treated with EPOCH ± R: does HIV status matter?

  • Authors : McNally GA; The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.; Aossey CM

Subjects: Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/chemically induced ; Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/epidemiology ; Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/Peripheral Nervous System Diseases*/diagnosis EPOCH protocol

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1110-1116. Date of Electronic Publication: 2024 Apr 22.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Metabolic tumour area: a novel prognostic indicator based on 18 F-FDG PET/CT in patients with diffuse large B-cell lymphoma in the R-CHOP era.

  • Authors : Cui S; Department of Nuclear Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu, China.; Institute of Clinical Translation of Nuclear Medicine and Molecular Imaging, Soochow University, Changzhou, Jiangsu, China.

Subjects: Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/drug therapy ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/diagnostic imaging ; Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/Lymphoma, Large B-Cell, Diffuse*/mortality

  • Source: BMC cancer [BMC Cancer] 2024 Jul 25; Vol. 24 (1), pp. 895. Date of Electronic Publication: 2024 Jul 25.Publisher: BioMed Central Country of Publication: England NLM ID: 100967800 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2407

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Effect of atorvastatin versus placebo on efficacy in patients with diffuse large B-cell lymphoma receiving R-CHOP.

Subjects: Atorvastatin*/Atorvastatin*/Atorvastatin*/therapeutic use ; Atorvastatin*/Atorvastatin*/Atorvastatin*/administration & dosage ; Atorvastatin*/Atorvastatin*/Atorvastatin*/adverse effects

  • Source: Leukemia & lymphoma [Leuk Lymphoma] 2024 Jun; Vol. 65 (6), pp. 783-788. Date of Electronic Publication: 2024 Feb 21.Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  4,983 نتائج ل ""DOXORUBICIN""